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Abstract
Objective: To evaluate a short screening sheet (SSM) for malnutrition and to investigate the nutritional status
of patients receiving chemotherapy for cancer of the lungs, colon or breast at an outpatient clinic.
Design: Full nutritional assessment was conducted to define malnutrition and validate the SSM. Additionally,
weight change from earlier healthy weight was evaluated, and calculations for intake of energy-giving
nutrients (three-day-weighed food records) and protein balance were performed. After the evaluation study,
the SSM was tested in clinical routine and data collected about patients’ need for nutritional counseling.
Subjects: Patients at the outpatient clinic of the Department of Oncology at Landspitali-University Hospital
(n30 with lung-, colon- or breast cancer in the study population, n93 with all cancer type in clinical
routine screening).
Results: Malnutrition was defined by full nutritional assessment in 20% of the participating patients and SSM
had high sensitivity and specificity. Declining nutritional status of the patients was seen as a negative nitrogen
balance and unintentional weight loss from healthy weight, but not as total energy intake, recent weight loss
or underweight. The test of SSM in clinical routine showed that 40% were malnourished. According to the
patients, 80% needed nutritional counseling but only 17% had such counseling.
Conclusion: Screening (SSM) for malnutrition in cancer patients is a valid simple approach to define cancer
patients for nutritional care. More patients regard themselves in need for nutritional counseling than the
number of patients really achieving any.
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M
alnutrition in cancer increases the risk of
infections and the cost of healthcare. It de-
creases the patients’ quality of life (QoL),
affecting both responses to anticancer treatment and
overall survival (15).
Fundamental to tackling the malnutrition problem is
to detect it. Nutritional screening should provide the
opportunity to identify malnutrition or individuals at
high nutritional risk at an early stage of medical care in a
non-invasive, inexpensive and feasible way. Routine
screening of patients to identify risk of malnutrition has
been recommended by many national, international and
specialist organizations (6, 7).
The lungs, colon and breasts are leading sites of cancer
in westernized countries (8). These cancers are commonly
treated with chemotherapy, which often has adverse effect
on the nutritional status of the affected patient. More
knowledge is needed about the nutritional status and diet
of patients in chemotherapy for lung, colon and breast
cancer.
The aim of the present study was to evaluate a simple
screening tool for malnutrition (short screening sheet,
SSM) of patients in chemotherapy for cancer of the lungs,
colon and breasts at an outpatient clinic using full
nutritional assessment as the reference. Dietary intake
and nitrogen balance were also investigated in the patient
group. Finally, the screening tool was tested in cancer
patients in chemotherapy in a clinical routine.
Methods
Study sample
The participants (n30) constituted 38% of all patients
in chemotherapy at the Department of Oncology at
Landspitali-University Hospital with breast, colon or
lung cancer. The mean age was 55 years (range 2972
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DOI: 10.3402/fnr.v52i0.1856years) (Table 1). All patients with breast, colon or lung
cancer (n79) were invited to participate in the study
during the data collection. The most common explana-
tion for not participating was that ‘people were too sick’
or ‘the burden of the study was too heavy’.
All patients were asked about their usual physical
activity. They were all sedentary or had a low physical
activity level (PAL). The mean body mass index (BMI)
was 2796 kg/m
2 and 15 were overweight or obese
patients with BMI over 25, two were underweight with
BMI below 20.
The study was approved by the Local Ethical Com-
mittee at Landspitali-University Hospital in Reykjavik,
Iceland.
Nutritional assessment
Full nutritional assessment
A full nutritional assessment was conducted as described
earlier (911) by measurements of BMI, triceps skinfold
thickness (TST), mid-arm muscle circumference
(MAMC), serum albumin (alb), serum prealbumin
(palb), total lymphocyte count (TLC) and unintentional
weight loss of more than 5% within the preceding month
or 10% or more within the previous 6 months (10).
Malnutrition was defined as present when three or more
of these seven parameters were subnormal. In addition,
weight change from patients’ self-reported earlier healthy
weight was evaluated.
Biochemical measures and reference values were ob-
tained from the laboratory at Landspitali-University
Hospital. Values for TST and MAMC (Table 2) were
compared with normal values from the National Health
and Nutrition Examination Survey (NHANES) as de-
scribed previously (10).
Nutritional screening
The SSM sheet (Fig. 1, (10)) is made up of seven
questions covering BMI, weight loss, anorexia, surgery
and other variables that may influence nutritional status.
No measurements other than weight and height were
needed for answering the questions. Each question gave a
score according to the answers. The criterion set for
malnutrition was a total score of five or more points.
Food record
Three-day-weighed food records were completed for all
patients (n30) participating in the study and assumed
to be sufficient for estimating energy and protein intake
on an individual basis (12). Patients did the food record
between chemotherapies when they were feeling better,
usually starting on fourth or fifth day after chemother-
apy.
The intake of macronutrients, energy, protein, fat, and
carbohydrates was analyzed for each patient using
KOSTPLAN for Windows, version 1.0 (AIVO AB,
Stockholm, 1996).
Table 1. Characteristics of the cancer patients (mean9SD)
Male (n9) Female (n21) All (n3)
Age (y) 60911 53912 55912
Weight (kg) 89926 72915 77920
Height (cm) 17997 16796 17099
BMI 28982 6 952 7 96
BMR (kcal/d, calculated) 16399162 13319102 14239187
Breast cancer (n19) Female (n19)
Age 53912
Weight 73915
Height 16895
BMI 2695
BMR 13359102
Colon cancer (n8) Male (n7) Female (n1) All (n3)
Age 61910 58 6199
Weight 91930 57 87930
Height 18097 150 176913
BMI 28992 5 2 8 98
BMR 15799158 1128 15229210
Lung cancer (n3) Male (n2) Female (n1) All (n3)
Age 57917 49 54913
Weight 79937 0 7 6 95
Height 17498 160 169910
BMI 26932 7 2 7 92
BMR 15119289 1265 14289249
Table 2. Mean value9SD and reference value of nutritional para-
meters used for the full nutritional assessment of cancer patients
(n30)
Parameters Male
(n9)
Female
(n21)
Mean
(n30)
Reference
Alb (g/L) 41918 36933 8 910 3851
Palb (mg/L) 304967 268949 279956 180450
TLC (10
9) 1.690.9 1.190.6 1.390.8  1.8
BMI (kg/m
2)2 8 982 6 952 7 96  20
TST (mm) 7921 6 951 3 96  5%**
MAMC (cm) 33943 2 953 2 95  5%**
MAMA (cm
2)8 5 925 83926 84925  5%**
UWL (kg) 198* 298* 198* B5%
Albalbumin; Palbprealbumin; TLCtotal lymphocyte count;
BMIbody mass index; TSTtriceps skinfold thickness; MAMA
mid-arm muscle area; MAMCmid-arm muscle circumference;
UWLunintentional weight loss previous month.
*Mean weight loss () or weight gain ().
**NHANES (19711974).
Olof G. Geirsdottir and Inga Thorsdottir
2
(page number not for citation purpose)The basal energy expenditure was estimated using the
HarrisBenedict equation (13). Studies have shown that
an adjusted body weight equal to the ideal body,
according to Hamwi equation (14), weight plus 50% of
the excess body weight provides the most accurate
estimate of the energy expenditure. Adjusted body weight
was used for obese patients (n5), in the Harris
Benedict equation (15). Disease-specific stress and activ-
ity factors were used when the total energy expenditure
was calculated (15).
Nitrogen balance
Total urinary nitrogen (16) was together with total
protein intake (g protein/6.25), used to estimate nitrogen
balance. The loss from routes other than urine was
estimated to be 2 g/24 hour (17). The patients were asked
NATIONAL UNIVERSITY HOSPITAL 
Department of Clinical Nutrition        SCREENING  FOR  MALNUTRITION 
This screening sheet should be used to assess the  
need for nutritional therapy among adult patients. 
Answer the following questions and give score accordingly. 
PATIENT’S  I.D.
QUESTION     ANSWER          ASSESSMENT              SCORES 
1. Height:_______m 
Weight:_______kg
BMI: Kg/m² 
___________ 
>20                                0 scores 
18-20:                            2 scores 
< 18:                              4 scores  ______ 
2. Recent unintentional weight loss? 
If yes, how much?           ______kg 
In what time period?       ______months 
    Yes          No 
    Doesn´t 
know  
Weight loss % 
___________ 
Unintentional weight loss:
>5%  past month or 
> 10 % previous 6 mo.  4 scores 
5-10%        “   1-6 mo.   2 scores 
Doesn´t know                2 scores 
 Other                            0 scores 
______ 
o N s e Y ? s r a e y 5 6 r e v o e g A . 3 Question 3 to 8:
Yes:                               1 scores   
No:                                0 scores  ______ 
______ 
4.  Problems last weeks or months? 
        A. Vomiting lasting more than 3 days ? 
        B.  Daily diarrhoea 
              (more than 3 liquid stools per day)? 
        C.  Continuous loss of appetite or nausea? 
        D.  Difficulty in chewing or swallowing?         
    Yes          No 
    Yes          No 
    Yes          No 
    Yes          No 
______ 
______ 
______ 
______ 
5.  Hospitalised for 5 days or more during previous 2 months?  Yes          No  _ _ _ _ _ _
6.  Major surgery in the past month? 
If yes, list type __________________________________ 
    Yes          No 
______ 
7.  Diseases – 5 points 
Burn >15 % 
Malnutrition 
Multiple trauma 
    Yes          No  _ _ _ _ _ _
_ _ _ _ _ _
Completed by__________________________________________ 
signature 
Date__________  Sum 
scores __________ 
If a patient gets 5 or more scores, a referral should be sent to the department of clinical nutrition. 
For cancerpatients and patients with pulmonary diseases use 4 or more scores.
Fig. 1. Simple screening tool for malnutrition (SSM).
Nutritional status of cancer patients
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(page number not for citation purpose)to perform one consecutive 24-hour urine collection,
which took place on the second day of the weighed food
recording.
Evaluation of the SSM in clinical setting
Data were collected for one month screening period with
SSM. All cancer patient (n93) in cancer therapy at the
outpatient clinic of the Department of Oncology at
Landspitali-University Hospital were screened. None of
the 30 patients participating in the study to evaluate the
screening tool for malnutrition in cancer patients were
included. The screening included 50 women and 43 men,
age 58916 years (mean9standard deviation, SD) range
2296 years. In addition to the nutritional screening, the
patients were asked if they needed nutritional counseling
and if they had had any nutritional counseling before.
Statistical analysis
Results are presented as mean9SD. Data were analyzed
using the Statistical Package for the Social Sciences
(version 9.0 for Windows, 1999, SPSS, Chicago, IL) for
descriptive statistics to ascertain how many patients had
below-reference values on the different parameters as
described earlier (10). Sensitivity, specificity, and predic-
tive values were calculated to evaluate single parameters
and the screening sheet in comparison to full nutritional
assessment (18).
Results
Full nutritional assessment
According to the full nutritional assessment, six of the 30
(20%) cancer patients in chemotherapy were diagnosed as
malnourished. No patient showed subnormal serum
prealbumin or MAMC values (Table 2). BMI was
subnormal in two of the six malnourished patients, and
four of six patients with subnormal TST were malnour-
ished. Unintentional weight change ranged from a 22%
weight loss to 32% weight gain compared with recorded
weight at first visit to the oncology clinic. The uninten-
tional weight change was not significant due to this wide
range of patient’s weight changes. However, if the
patients’ self-reported earlier usual healthy weight was
the reference for unintentional weight loss, all of the
malnourished patients had lost considerable weight,
mean 7.993 kg (mean9SD).
Screening sheet
The SSM identified seven of 30 patients (23%) as
malnourished. The evaluation of SSM and the seven
single nutritional parameters used in the full nutritional
assessment to indicate malnutrition among cancer pa-
tients is shown in Table 3.
The SSM had a sensitivity of 0.83 and the specificity
was 0.96. Few individual nutritional parameters had
sensitivity above 0.5, and no parameter reached the
quality of the SSM. If the patients’ earlier self-reported
usual healthy weight was used as the reference for
unintentional weight loss, this was the single best para-
meter with high sensitivity (0.87) and specificity (0.88),
and 13% misclassification.
Food intake
The energy intake was 20329500 kcal/d (mean9SD),
range 11003200. Overweight cancer patients reported a
lower energy intake of 18379108 kcal/d (mean9SD)
than those not overweight 22279132 kcal/d (p0.03).
Malnourished cancer patients had higher energy intake
per kg body weight than those who were not malnour-
ished (p0.01), but total energy intake did not differ.
Energy and nutrient intakes are summarized in Table 4.
The average calculated basal energy expenditure was
14569169 kcal/24 hour. When energy intake was ex-
pressed as kcal/kg of actual weight, the average intake
Table 3. Statistical evaluation of indicators for malnutrition in cancer patients
SSM TST MAMC BMI 510%
weight loss
Alb Palb TLC
Sensitivity 0.83 0.67 0 0.17 0.17 1 0 1
Specificity 0.96 0.88 1 1 0.96 0.37 1 0.25
Positive predictive value 0.83 0.57 * 1 0.50 0.29 * 0.25
Negative predictive value 0.96 0.92 0.80 0.83 0.82 1 0.8 1
False positive 1300 1 1 5 0 1 8
False negative 1265 5 0 6 0
Misclassification rate 6.7 16.7 20.0 16.7 20.0 50.0 20.0 60.0
SSMscreening sheet; TSTtriceps skinfold thickness; MAMCmid-arm muscle circumference; BMIbody mass index; 510% unintentional weight
loss in last month; albserum albumin; palbserum prealbumin; TLCtotal lymphocyte count.
*No patient below reference value for this parameter.
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(page number not for citation purpose)was 28 (99) kcal/kg of body weight and 29 (98) kcal/kg
of ideal body weight for obese patients. Energy intake
averaged 144% of calculated basal energy expenditure,
using ideal body weight for obese patients.
Nitrogen balance
Dietary protein intake estimated from weighed food
records was 1.190.3 g/kg of ideal body weight. Nitrogen
excretion including 2 g/d estimated loss from non-urine
routes exceeded nitrogen intake by 2.494 g N/24 hour
and was significantly different from zero (p0.006). This
negative nitrogen balance means 15.5927.8 g/day protein
loss. Patients (n17) putting on weight or weight stable
in chemotherapy had significantly (p0.006) negative
nitrogen balance.
Evaluation of the SSM in clinical setting
Nutritional screening of all cancer patients (n93) at the
outpatients Department of Oncology with the SSM
indicated that 41% of the patients were malnourished.
According to the patients’ answers to the questions about
nutritional counseling, the majority (80%) needed dietary
counseling but only 17% had received such counseling
earlier.
Discussion
This study showed that 20% of cancer patients in an
outpatient clinic with a clinical diagnosis of breast, colon,
or lung cancer were malnourished. Weight loss and
malnutrition are common in patients with advanced
malignant diseases that adversely influence patient survi-
val and QoL (1921).
Unintentional weight loss has often been reported in
cancer patients (18) and regarded as a stronger variable
for detection of malnutrition than BMI (22, 23). In the
present study, general unintentional weight loss from
patients’ self-reported earlier usual healthy weight was
found to be the best single parameter for detecting
malnutrition. However, it did not reach the quality of
the SSM in terms of specificity and misclassification.
A majority of the patients had serum albumin (70%)
and TLC (80%) below the reference value. Previous
studies have implicated that pro-inflammatory tumor
derived mechanisms influence the hepatic acute phase
protein response, which makes measurements of serum
albumin and immunocompetence such as TLC of limited
value. Serum albumin is the most widely used clinical
index of nutrition, but because of its long half-life and
affection by stress and illness (24) it can be regarded as a
poor parameter of nutritional status. Also many cancer
therapy drugs cause low TLC and serum albumin (25).
This underlines that nutritional status cannot be evalu-
ated from one or two single parameters and supports the
need for several measurements as used in the present
study.
A large number of screening tools have been reported
and promoted in various settings. The main advantage of
the present SSM as a screening tool is that it is a very
simple tool, with only seven simple questions, and only
weight and height have to be measured. The SSM have
been validated with high sensitivity and are used in
routine clinical screening in other departments at Land-
spitali-University Hospital (911). Sensitivity in nutri-
tional screening is very important for realization of the
goal of finding malnourished patients, and specificity for
preventing well-nourished patients being classified as
malnourished. The sensitivity of the SSM was higher in
the present study of cancer patients than found in earlier
studies for other patient groups (9, 10, 26).
Energy and nutrient intake was within normal range.
However, our results show a significant negative nitrogen
balance and indicating that the majority (n21) of
patients were losing protein. The tendency of muscle
loss in cancer has been reviewed by others (27) with the
conclusion that many factors including patient’s age,
physical activity and cancer related protein metabolism
influence the skeletal muscle. Also drugs commonly used
in chemotherapy are known to cause negative nitrogen
balance (25). Aslani et al. (28) conclude that weight gain
observed during adjuvant chemotherapy for breast carci-
noma is primarily due to an increase in fat and total body
water. Negative nitrogen balance shows that a majority of
these cancer patients have aggravated nutritional status
even though some of the patients are putting on weight.
Therefore, the present study supports the assertion that
malnutrition and negative nitrogen balance in cancer
patients can be substantial without abnormal weight loss,
energy intake or BMI.
The study has limitations due to the high drop out rate
and a small number of patients who were investigated.
Only patients who considered that they could manage the
burden of the study participated. Therefore, it can be
speculated that the nutritional status is worse among
Table 4. Daily intake of energy and energy-giving nutrients in
cancer patients (n30), estimated from three-day-weighed food
records (mean9SD), and Nordic Nutrition Recommendations for
energy-giving nutrients (15)
Male (n9) Female (n21) Total (n30) NNR
Energy (kcal) 23279448 19069475 19059500
Protein (g/d) 101919 73919 76922
Protein (%E) 17931 6 921 6 931 0 15
Fat (g/d) 87923 75923 73923
Fat (%E) 33953 5 963 4 96 B30
CHO (g/d) 270945 224969 223966
CHO (%E) 47954 7 974 7 975 5 60
CHOcarbohydrate.
Nutritional status of cancer patients
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(page number not for citation purpose)patients with more severe types of cancer or those with
more severe side effects from the chemotherapy.
Data from one month screening with SSM indicated
that 41% of all cancer patients in chemotherapy were
malnourished or in nutritional risk. The majority of the
screened patients are regarded themselves in need of
nutritional counseling, but only few had received nutri-
tional counseling. This study supports other reports that
nutritional issues are underestimated in diagnostic and
therapeutic procedures (1, 19, 20). It has been concluded
from the results of other studies that early nutritional
support is necessary to improve patient’s nutrient status
and controlling complications related to food intake
which influence patients’ QoL (29). Nutritional interven-
tions can affect a cancer patient’s outcome. Nutrition is
more than just food; it is an essential part of clinical care
that can be improved.
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